Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Queen

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1992
Chimeric and humanized antibodies with specificity for the CD33 antigenM S Co, N M Avdalovic, P C Caron, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1992
Mik-beta 1(Fv)-PE40, a recombinant immunotoxin cytotoxic toward cells bearing the beta-chain of the IL-2 receptorR J Kreitman, W P Schneider, C Queen, et al.
Molecular Immunology|October 1, 1993
Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibodyM S Co, D A Scheinberg, N M Avdalovic, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1994
Humanized monoclonal antibody DREG-200 directed against I-selectin protects in feline myocardial reperfusion injuryM Buerke, A S Weyrich, T Murohara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
Humanization and pharmacokinetics of a monoclonal antibody with specificity for both E- and P-selectinX Y He, Z Xu, J Melrose, et al.
Cancer Research|March 1, 1996
Humanized anti-Lewis Y antibodies: in vitro properties and pharmacokinetics in rhesus monkeysM S Co, J Baker, K Bednarik, et al.
Cancer|February 1, 1994
Murine and humanized constructs of monoclonal antibody M195 (anti-CD33) for the therapy of acute myelogenous leukemiaP C Caron, M A Schwartz, M S Co, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991
Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survivalP S Brown, G L Parenteau, F M Dirbas, et al.
Nature Biotechnology|December 16, 1998
A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpesL Zeitlin, S S Olmsted, T R Moench, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989
A humanized antibody that binds to the interleukin 2 receptorC Queen, W P Schneider, H E Selick, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1992
Chimeric and humanized antibodies with specificity for the CD33 antigenM S Co, N M Avdalovic, P C Caron, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1992
Mik-beta 1(Fv)-PE40, a recombinant immunotoxin cytotoxic toward cells bearing the beta-chain of the IL-2 receptorR J Kreitman, W P Schneider, C Queen, et al.
Molecular Immunology|October 1, 1993
Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibodyM S Co, D A Scheinberg, N M Avdalovic, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1994
Humanized monoclonal antibody DREG-200 directed against I-selectin protects in feline myocardial reperfusion injuryM Buerke, A S Weyrich, T Murohara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
Humanization and pharmacokinetics of a monoclonal antibody with specificity for both E- and P-selectinX Y He, Z Xu, J Melrose, et al.
Cancer Research|March 1, 1996
Humanized anti-Lewis Y antibodies: in vitro properties and pharmacokinetics in rhesus monkeysM S Co, J Baker, K Bednarik, et al.
Cancer|February 1, 1994
Murine and humanized constructs of monoclonal antibody M195 (anti-CD33) for the therapy of acute myelogenous leukemiaP C Caron, M A Schwartz, M S Co, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991
Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survivalP S Brown, G L Parenteau, F M Dirbas, et al.
Nature Biotechnology|December 16, 1998
A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpesL Zeitlin, S S Olmsted, T R Moench, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989
A humanized antibody that binds to the interleukin 2 receptorC Queen, W P Schneider, H E Selick, et al.
Pageof 6